ArticleInvestigational new drugs2022

Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.

Lu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.